FDA Drug Approvals: Neurology — Year in Review 2018

Mary L Windle, PharmD

Disclosures

January 15, 2019

New Drugs for Migraine
Aimovig (erenumab), Ajovy (fremanezumab), Emgality (galcanezumab)
New Drugs for Seizures
Diacomit (stiripentol), Epidiolex (cannabidiol)
Other Neurology Drug Approvals
Onpattro (patisiran), Tegsedi (inotersen), Galafold (migalastat), Firdapse (amifampridine phosphate)

1 2 3 4

Next Section

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Mary L Windle. FDA Drug Approvals: Neurology — Year in Review 2018 - Medscape - Jan 15, 2019.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....

FDA Drug Approvals: Neurology — Year in Review 2018

Tables

Authors and Disclosures

Authors and Disclosures

Author(s)

Mary L Windle, PharmD

Comments

Email This

Feedback